Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gitte M Knudsen

Showing results (121-130 of 342) with videos related to

Pageof 35
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 30, 2024
The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in bloodClara A Madsen, Miriam L Navarro, Betina Elfving, et al.
Psychopharmacology|July 13, 2010
Cognitive function is related to fronto-striatal serotonin transporter levels--a brain PET study in young healthy subjectsKarine Madsen, David Erritzoe, Erik Lykke Mortensen, et al.
Alcohol, Clinical & Experimental Research|March 24, 2025
Blood phosphatidylethanol measurements indicate GLP-1 receptor stimulation causes delayed decreases in alcohol consumptionMathias E Jensen, Mette K Klausen, Marianne L Bergmann, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2013
Serotonin 2A receptors, citalopram and tryptophan-depletion: a multimodal imaging study of their interactions during response inhibitionJulian Macoveanu, Bettina Hornboll, Rebecca Elliott, et al.
Journal of Nuclear Medicine Technology|November 11, 2011
Validation of a method for accurate and highly reproducible quantification of brain dopamine transporter SPECT studiesPeter S Jensen, Morten Ziebell, Glenna Skouboe, et al.
The International Journal of Neuropsychopharmacology|July 8, 2010
Blood BDNF concentrations reflect brain-tissue BDNF levels across speciesAnders B Klein, Rebecca Williamson, Martin A Santini, et al.
Journal of Clinical Psychopharmacology|February 21, 2013
Norquetiapine and depressive symptoms in initially antipsychotic-naive first-episode schizophreniaHans Rasmussen, Bjørn H Ebdrup, Bodil Aggernaes, et al.
Neuroscience Letters|October 20, 2007
Selective immunolesion of cholinergic neurons leads to long-term changes in 5-HT2A receptor levels in hippocampus and frontal cortexMaurizio Severino, Anja F Pedersen, Viktorija Trajkovska, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 3, 2008
Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transportStina Syvänen, Orjan Lindhe, Mikael Palner, et al.
Chemical Research in Toxicology|December 17, 2015
Metabolic Fate of Hallucinogenic NBOMesSebastian Leth-Petersen, Charlotte Gabel-Jensen, Nic Gillings, et al.
Pageof 35

Showing results (121-130 of 342) with videos related to

Sort By:
Pageof 35
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 30, 2024
The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in bloodClara A Madsen, Miriam L Navarro, Betina Elfving, et al.
Psychopharmacology|July 13, 2010
Cognitive function is related to fronto-striatal serotonin transporter levels--a brain PET study in young healthy subjectsKarine Madsen, David Erritzoe, Erik Lykke Mortensen, et al.
Alcohol, Clinical & Experimental Research|March 24, 2025
Blood phosphatidylethanol measurements indicate GLP-1 receptor stimulation causes delayed decreases in alcohol consumptionMathias E Jensen, Mette K Klausen, Marianne L Bergmann, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2013
Serotonin 2A receptors, citalopram and tryptophan-depletion: a multimodal imaging study of their interactions during response inhibitionJulian Macoveanu, Bettina Hornboll, Rebecca Elliott, et al.
Journal of Nuclear Medicine Technology|November 11, 2011
Validation of a method for accurate and highly reproducible quantification of brain dopamine transporter SPECT studiesPeter S Jensen, Morten Ziebell, Glenna Skouboe, et al.
The International Journal of Neuropsychopharmacology|July 8, 2010
Blood BDNF concentrations reflect brain-tissue BDNF levels across speciesAnders B Klein, Rebecca Williamson, Martin A Santini, et al.
Journal of Clinical Psychopharmacology|February 21, 2013
Norquetiapine and depressive symptoms in initially antipsychotic-naive first-episode schizophreniaHans Rasmussen, Bjørn H Ebdrup, Bodil Aggernaes, et al.
Neuroscience Letters|October 20, 2007
Selective immunolesion of cholinergic neurons leads to long-term changes in 5-HT2A receptor levels in hippocampus and frontal cortexMaurizio Severino, Anja F Pedersen, Viktorija Trajkovska, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 3, 2008
Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transportStina Syvänen, Orjan Lindhe, Mikael Palner, et al.
Chemical Research in Toxicology|December 17, 2015
Metabolic Fate of Hallucinogenic NBOMesSebastian Leth-Petersen, Charlotte Gabel-Jensen, Nic Gillings, et al.
Pageof 35